Article ; Online: Progestogens and pregnancy loss.
Climacteric : the journal of the International Menopause Society
2018 Volume 21, Issue 4, Page(s) 380–384
Abstract: Progestational agents are often prescribed to prevent pregnancy loss. Progestogens affect implantation, cytokine balance, natural killer cell activity, arachidonic acid release and myometrial contractility. Progestogens have therefore been used at all ... ...
Abstract | Progestational agents are often prescribed to prevent pregnancy loss. Progestogens affect implantation, cytokine balance, natural killer cell activity, arachidonic acid release and myometrial contractility. Progestogens have therefore been used at all stages of pregnancy including luteal-phase support prior to pregnancy, threatened miscarriage, recurrent miscarriage, and to prevent preterm labor. In luteal support, a Cochrane review reported that progestogens were associated with a higher rate of live births or ongoing pregnancy in the progesterone group (odds ratio 1.77, 95% confidence interval (CI) 1.09-2.86). Evidence suggests that progestogens are also effective for treating threatened miscarriage. Again, in a Cochrane Database review, progestogens were associated with a reduced odds ratio of 0.53 (95% CI 0.35-0.79) when progestogens were used. In recurrent miscarriage, progestogens also seem to have a beneficial effect. A meta-analysis of progestational agents showed a 28% increase in the live birth rate (relative risk 0.72, 95% CI 0.53-0.97). For the last 30 years, progestogens have been used to prevent preterm labor. Recent meta-analyses also report beneficial effects. This review summarizes the literature and the author's experience using progestogens to prevent pregnancy loss. |
---|---|
MeSH term(s) | Abortion, Habitual/prevention & control ; Abortion, Threatened/prevention & control ; Female ; Humans ; Obstetric Labor, Premature/prevention & control ; Pregnancy ; Progesterone/adverse effects ; Progesterone/therapeutic use ; Progestins/adverse effects ; Progestins/therapeutic use ; Randomized Controlled Trials as Topic |
Chemical Substances | Progestins ; Progesterone (4G7DS2Q64Y) |
Language | English |
Publishing date | 2018-03-22 |
Publishing country | England |
Document type | Journal Article ; Meta-Analysis ; Review |
ZDB-ID | 1469153-x |
ISSN | 1473-0804 ; 1369-7137 |
ISSN (online) | 1473-0804 |
ISSN | 1369-7137 |
DOI | 10.1080/13697137.2018.1436166 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 5245: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.